Reading a label
No monograph is not a clean bill of health
An absent monograph is not a clean bill of health. When the NIH Office of Dietary Supplements, NCCIH and Memorial Sloan Kettering all carry nothing on an ingredient, it means nobody has assembled the evidence — not that the evidence is good and not that it is bad. This post is about what to do with that silence, and why filling it is the most common failure in supplement writing.
What a monograph is
A monograph is a structured summary of everything known about a substance, written by an organisation with no product to sell. It typically covers what the substance is, what it is used for, what the clinical evidence shows, what the adverse effects are, and what it interacts with.
The value is not that a monograph is infallible. It is that it is accountable and dated. Somebody put their institution’s name to a summary of the literature at a point in time, and if the literature moves, the monograph gets revised. That is a different kind of object from a paragraph on a retailer’s website.
It is also a filter. The organisations that write monographs decline to write them about substances where there is not enough to summarise, and that declining is itself information.
The three bodies, and why only three
NIH Office of Dietary Supplements
Fact sheets on vitamins, minerals and botanicals, written in two versions — one for consumers and one for health professionals. The professional version carries intake data, upper limits and the reasoning behind them.
NCCIH
The National Center for Complementary and Integrative Health, part of the NIH. Covers herbs and practices, and publishes review digests that summarise whole categories rather than single ingredients.
Memorial Sloan Kettering — About Herbs
A clinician-facing botanical database with an explicit do-not-take list on each entry. The most directly useful of the three when the question is about interactions.
And the FDA, for rules rather than evidence
Labelling requirements, the position on pre-market approval, and the enforcement databases. Not a source about whether an ingredient works.
Why stop at three? Because the list has to stop somewhere, and each step down it trades accountability for coverage. There are excellent regional and academic sources beyond these. There are also thousands of pages that look similar, are written by whoever is selling the ingredient, and cite one another in a circle.
A short list that is applied consistently is more useful than a long one applied when convenient. When a site quotes three institutional sources for five ingredients and a supplier’s brochure for the sixth, the sixth is where the argument is being made.
What silence means, and what it does not
What an absent monograph does mean
- No accountable organisation has assembled the evidence on this ingredient.
- There is no dated, revisable summary to compare a product against.
- There is no institutional statement of the interactions, which matters more than the efficacy question.
- Anybody writing confidently about it is writing from something other than these sources.
What it does not mean
- That the ingredient is unsafe. Nothing has been established either way.
- That the ingredient is useless. Absence of evidence is not evidence of absence.
- That no research exists. Individual papers may exist without anyone having summarised them.
- That the ingredient is obscure. Some of the most heavily sold botanicals have no monograph anywhere.
That last point is the one worth sitting with. Commercial popularity and institutional documentation are almost unrelated. An ingredient can be in ten thousand products and have no entry at any of the three bodies above, because what drives its presence on shelves is marketing infrastructure rather than a literature.
Why the gap gets filled anyway
A page with a heading and nothing under it looks like a failure. A writer facing an ingredient with no monograph has a strong incentive to find something, and there is always something to find.
The something is usually one of five things, and all five are worth recognising on sight.
The five substitutes to distrust
- The supplier’s technical brochure. Written by the company selling the raw material, styled like a scientific document, and reproduced across hundreds of sites until it reads like consensus.
- A single small study, described as ‘research shows’. One trial of twenty people is a hypothesis. The phrasing converts it into a body of knowledge.
- An animal or in-vitro finding, described in human terms. A compound that does something to isolated cells at a concentration unachievable in a person is a lead, not a mechanism.
- Traditional use, presented as evidence of effect. Long use tells you a substance is probably not acutely toxic. It does not tell you it works, and the two get conflated constantly.
- Citation laundering. Site A makes a claim, site B cites A, site C cites B, and by site D there is a reference list. Following one of these chains to its origin is a dispiriting exercise and a useful one.
The common feature of all five is that they produce text where there should be a gap. And text where there should be a gap is worse than the gap, because it removes the reader’s reason to be careful.
What we do instead
Two of the seven ingredients in the product this site sells have no monograph at any of the three bodies above: sarsaparilla and tongkat ali. The second of those is the ingredient the product leads with.
The entries for both on the ingredients page are conspicuously shorter than the other five. They say what the label states, they say that no monograph was found, and they stop. There is no paragraph about traditional Southeast Asian use, no summary of a supplier brochure, and no reference list assembled from other retailers.
That is a worse page by most measures anybody uses to judge a page. It is also the only version of it that is true, and the alternative — writing something plausible — is exactly the failure this post is about.
The same rule produces the missing list, which is a page on this site whose entire content is facts we could not obtain. It is there for the same reason.
How to check for yourself, in four minutes
This is not specialist work. Anyone can run the same check this desk runs, on any ingredient, and it takes about four minutes.
Search the NIH Office of Dietary Supplements
Its fact sheets come in a consumer version and a health-professional version. Read the professional one: it carries intake figures, upper limits and the reasoning.
Search NCCIH
Herbs and practices, plus review digests that summarise whole categories. The digest for this category is one of the most useful documents in it.
Search Memorial Sloan Kettering's About Herbs
The most directly useful of the three for interactions, because every entry carries an explicit do-not-take list.
Write down what you did not find
This is the step nobody takes, and it is the one that matters. A negative result is a result, and recording it stops you quietly filling the gap later with whatever turns up on a fourth search.
Run that on the seven ingredients in the product this site sells and you will reproduce our findings, including the two blanks. That is the point of publishing the method rather than only the conclusion.
Why we do not go to PubMed for this
A reasonable objection: individual studies exist for ingredients with no monograph, and PubMed indexes them. Why not cite those?
Because reading primary literature well is a skill, and reading it badly is worse than not reading it. A single trial is a data point whose weight depends on its size, its design, its blinding, its endpoint, its funding, its statistical handling and whether it has been replicated. A monograph is somebody accountable having already weighed all of that.
A retailer citing three hand-picked studies for an ingredient is doing something that looks like evidence and is closer to the opposite, because the selection is invisible and the selector is selling something. If twelve trials exist and four are positive, a page citing the four has a reference list and no honesty.
There is also a specific trap in this category. Much of the primary literature on the marketed-for-testosterone botanicals is small, short, industry-funded and published in journals that do not index their retractions. A monograph author knows how to weight that. A retailer looking for a citation does not, and the incentive runs the wrong way.
So the rule here is simple: three bodies, quoted directly, and silence where they are silent. It produces a thinner site and a more honest one.
Read the panel first, then decide
Sixty capsules, two a day, seven actives itemised and two extract ratios printed — better label work than most of this aisle. What is missing is standardisation, and two of the seven ingredients have no monograph anywhere we looked. The live price and the 60-day return terms are both on the seller’s checkout screen.
60-day window · Questions first? Call +1 (302) 200-3480